ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,099Medicare Part D Prescriptions Filled, Including Refills

Rank: 191 out of 1206

$494K Total Retail Price of All Prescriptions

Rank: 171 out of 1206

396 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 396 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 396 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,975 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
FUROSEMIDE 453 378 1 5
HYDROCODONE-ACETAMINOPHEN 351 181 S3 2 7
OMEPRAZOLE 322 274 3 3
LEVOTHYROXINE SODIUM 305 250 4 2
METFORMIN HCL 284 201 5 10
LISINOPRIL 280 230 6 4
POTASSIUM CHLORIDE 246 222 7 12
SIMVASTATIN 219 199 8 1
METOPROLOL TARTRATE 207 157 9 9
WARFARIN SODIUM 197 157 10 8
POLYETHYLENE GLYCOL 3350 188 188 11 31
TRAMADOL HCL 182 140 12 17
AMLODIPINE BESYLATE 145 123 13 6
CARVEDILOL 119 115 14 32
FENTANYL 115 84 S2 15 51
ATORVASTATIN CALCIUM 114 87 16 13
PAROXETINE HCL 114 87 16 53
CITALOPRAM HBR 111 104 18 16
LANTUS 107 86 19 38
ATENOLOL 102 87 20 14
ESCITALOPRAM OXALATE 98 77 21 86
ALLOPURINOL 98 83 21 24
HYDROCHLOROTHIAZIDE 96 81 23 11
ISOSORBIDE MONONITRATE ER 95 93 24 40
METOPROLOL SUCCINATE 94 87 25 15
RISPERIDONE 87 80 26 74
GLIPIZIDE 77 68 27 64
LEVOFLOXACIN 75 61 28 78
TRIAMTERENE-HCTZ 75 45 28 33
NAMENDA 74 72 30 36
ZOLPIDEM TARTRATE 74 57 30 25
CLOPIDOGREL 73 64 32 48
LOSARTAN POTASSIUM 73 70 32 20
GLYBURIDE 72 68 R 34 69
OXYBUTYNIN CHLORIDE ER 71 59 35 119
SPIRONOLACTONE 70 44 36 41
ALENDRONATE SODIUM 67 61 37 19
VERAPAMIL ER 64 43 38 97
FAMOTIDINE 64 53 38 65
PLAVIX 63 61 40 72
DILTIAZEM 24HR CD 61 53 41 67
RAMIPRIL 61 61 41 96
TRAZODONE HCL 57 16 43 37
AZITHROMYCIN 56 31 44 46
SPIRIVA 56 33 44 66
NOVOLIN R 55 46 46 326
NOVOLOG 55 47 46 100
PROPRANOLOL HCL 55 31 46 92
MIRTAZAPINE 52 46 49 50
ACTOS 51 51 50 98
DIGOXIN 50 40 51 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.